Simon Wandel

8.6k total citations · 5 hit papers
37 papers, 4.2k citations indexed

About

Simon Wandel is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Statistics and Probability. According to data from OpenAlex, Simon Wandel has authored 37 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Cardiology and Cardiovascular Medicine and 9 papers in Statistics and Probability. Recurrent topics in Simon Wandel's work include Coronary Interventions and Diagnostics (9 papers), Statistical Methods in Clinical Trials (7 papers) and Cardiac Imaging and Diagnostics (5 papers). Simon Wandel is often cited by papers focused on Coronary Interventions and Diagnostics (9 papers), Statistical Methods in Clinical Trials (7 papers) and Cardiac Imaging and Diagnostics (5 papers). Simon Wandel collaborates with scholars based in Switzerland, United States and United Kingdom. Simon Wandel's co-authors include Peter Jüni, Matthias Egger, Sven Trelle, Peter M. Villiger, Stephan Reichenbach, Pius Hildebrand, Beat Neuenschwander, Robert Colebunders, Hansjakob Furrer and Suzanna Attia and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Oncology.

In The Last Decade

Simon Wandel

37 papers receiving 4.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

2011 827 citations Sven Trelle, Stephan Reichenbach et al. BMJ profile →
Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis

2010 524 citations Mónika Müller, Simon Wandel et al. The Lancet Infectious Diseases profile →
MEK162 for patients with advanced melanoma harbouring NRAS or Val600 BRAF mutations: a non-randomised, open-label phase 2 study

2013 499 citations Simon Wandel et al. profile →
Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial

2008 453 citations Stephan Windecker, Patrick W. Serruys et al. The Lancet profile →
Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis

2010 396 citations Simon Wandel, Peter Jüni et al. BMJ profile →

Peers

Countries citing papers authored by Simon Wandel

Since Specialization

Citations

This map shows the geographic impact of Simon Wandel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Wandel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Wandel more than expected).

Fields of papers citing papers by Simon Wandel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Wandel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Wandel. The network helps show where Simon Wandel may publish in the future.

Co-authorship network of co-authors of Simon Wandel

This figure shows the co-authorship network connecting the top 25 collaborators of Simon Wandel. A scholar is included among the top collaborators of Simon Wandel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon Wandel. Simon Wandel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Beyond the Classical Type I Error: Bayesian Metrics for Bayesian Designs Using Informative Priors 2024 ·Statistics in Biopharmaceutical Research ·Nicky Best, (unknown), Beat Neuenschwander, Gaëlle Saint‐Hilary, Simon Wandel	5
2	Independence of Lipoprotein(a) and Low-Density Lipoprotein Cholesterol–Mediated Cardiovascular Risk: A Participant-Level Meta-Analysis 2024 ·Circulation ·Harpreet Bhatia, Simon Wandel, Peter Willeit, Anastasia Lesogor, (unknown), Paul M. Ridker, Paul J. Nestel, R. J. Simes, Andrew Tonkin, Gregory G. Schwartz, Helen M. Colhoun, Christoph Wanner, Sotirios Tsimikas	26
3	Rethinking clinical study data: why we should respect analysis results as data 2022 ·Scientific Data ·(unknown), (unknown), Mark Baillie, Simon Wandel	3
4	Innovations in Pediatric Therapeutics Development: Principles for the Use of Bridging Biomarkers in Pediatric Extrapolation 2022 ·Therapeutic Innovation & Regulatory Science ·Thomas R. Fleming, Christine Garnett, Laurie S. Conklin, Solange Corriol‐Rohou, S. Hariharan, Daphne T. Hsu, Guenther Mueller‐Velten, Yeruk Mulugeta, Ronald J. Portman, Mark D. Rothmann, Norman Stockbridge, Simon Wandel, Jialü Zhang, Lynne Yao	10
5	Predicting drug approvals: The Novartis data science and artificial intelligence challenge 2021 ·Patterns ·Kien Wei Siah, Nicholas Kelley, (unknown), Björn Holzhauer, Tianmeng Lyu, (unknown), Sophie Sun, Simon Wandel, Zhong Yang, Bin Zhou, Shifeng Pan, Yingyao Zhou, Andrew W. Lo	25
6	Model averaging for robust extrapolation in evidence synthesis 2018 ·Statistics in Medicine ·Christian Röver, Simon Wandel, Tim Friede	23
7	Renin angiotensin system inhibitors for patients with stable coronary artery disease without heart failure: systematic review and meta-analysis of randomized trials 2017 ·BMJ ·Sripal Bangalore, Robert J. Fakheri, Simon Wandel, Bora Toklu, Jasmin Wandel, Franz H. Messerli	52
8	Meta‐analysis of few small studies in orphan diseases 2016 ·Research Synthesis Methods ·Tim Friede, Christian Röver, Simon Wandel, Beat Neuenschwander	127
9	Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis breakdown → 2011 ·BMJ ·Sven Trelle, Stephan Reichenbach, Simon Wandel, Pius Hildebrand, (unknown), Peter M. Villiger, Matthias Egger, Peter Jüni	827
10	How Valuable are Multiple Treatment Comparison Methods in Evidence-Based Health-Care Evaluation? 2011 ·Value in Health ·Nicola J. Cooper, Jaime Peters, (unknown), Peter Jüni, Simon Wandel, Steve Palmer, Mike Paulden, Stefano Conti, Nicky J. Welton, Keith R. Abrams, Sylwia Bujkiewicz, David J. Spiegelhalter, Alex J. Sutton	55
11	Sirolimus versus paclitaxel coronary stents in clinical practice 2010 ·Catheterization and Cardiovascular Interventions ·(unknown), Peter Jüni, (unknown), Simon Wandel, (unknown), Michael Billinger, (unknown), Peter Wenaweser, G Hellige, Lorenz Räber, Stéphane Cook, Rolf Vogel, Mario Togni, Christian Seiler, Bernhard Meier, Stephan Windecker	8
12	Effects of glucosamine, chondroitin, or placebo in patients with osteoarthritis of hip or knee: network meta-analysis breakdown → 2010 ·BMJ ·Simon Wandel, Peter Jüni, Britta Tendal, Eveline Nüesch, Peter M. Villiger, Nicky J. Welton, Stephan Reichenbach, Sven Trelle	396
13	Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis breakdown → 2010 ·The Lancet Infectious Diseases ·Mónika Müller, Simon Wandel, Robert Colebunders, Suzanna Attia, Hansjakob Furrer, Matthias Egger	524
14	Impact of arterial injury on neointimal hyperplasia after implantation of drug-eluting stents in coronary arteries: an intravascular ultrasound study 2010 ·EuroIntervention ·Parham Eshtehardi, Stéphane Cook, Simon Wandel, Lorenz Räber, Peter Wenaweser, Mario Togni, Rolf Vogel, Ali Garachemani, Franz R. Eberli, Thomas F. Lüscher, Peter Jüni, Otto M. Hess, Bernhard Meier, Stephan Windecker	9
15	Disagreements in meta-analyses using outcomes measured on continuous or rating scales: observer agreement study 2009 ·BMJ ·Britta Tendal, Julian P. T. Higgins, Peter Jüni, Asbjørn Hróbjartsson, Sven Trelle, Eveline Nüesch, Simon Wandel, Anders W Jørgensen, (unknown), (unknown), Peter C Gøtzsche	61
16	An optical coherence tomography study of a biodegradable vs. durable polymer-coated limus-eluting stent: a LEADERS trial sub-study 2009 ·European Heart Journal ·Peter Barlis, E. Regar, Patrick W. Serruys, Konstantinos Dimopoulos, Wim J. van der Giessen, Robert‐Jan van Geuns, Giuseppe Ferrante, Simon Wandel, Stephan Windecker, (unknown), Pedro Eerdmans, Peter Jüni, Carlo Di Mario	185
17	Biolimus-eluting stent with biodegradable polymer versus sirolimus-eluting stent with durable polymer for coronary revascularisation (LEADERS): a randomised non-inferiority trial breakdown → 2008 ·The Lancet ·Stephan Windecker, Patrick W. Serruys, Simon Wandel, Paweł Buszman, (unknown), Axel Linke, Karsten Lenk, Thomas Ischinger, Volker Klauß, Franz R. Eberli, Roberto Corti, William Wijns, Marie‐Claude Morice, Carlo Di Mario, Simon Davies, Robert‐Jan van Geuns, Pedro Eerdmans, Gerrit-Anne van Es, Bernhard Meier, Peter Jüni	453
18	Two-year clinical outcome after implantation of sirolimus-eluting and paclitaxel-eluting stents in diabetic patients 2008 ·European Heart Journal ·Michael Billinger, Jaap J. Beutler, (unknown), Andréa Remondino, P. Wenaweser, Stéphane Cook, Mario Togni, Christian Seiler, Christoph Stettler, Franz Eberli, Thomas F. Lüscher, Simon Wandel, Peter Jüni, B Meier, Stephan Windecker	56
19	Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies 2008 ·Sexually Transmitted Infections ·(unknown), Simon Wandel, Matthias Egger, Ram Rangsin, Kenrad E. Nelson, Caroline Costello, (unknown), Tom Lutalo, Anthony Ndyanabo, Jim Todd, Lieve Van der Paal, Albert Minga	60
20	Efficacy and safety of intraarticular hylan or hyaluronic acids for osteoarthritis of the knee: A randomized controlled trial 2007 ·Arthritis & Rheumatism ·Peter Jüni, Stephan Reichenbach, Sven Trelle, (unknown), Simon Wandel, (unknown), (unknown), (unknown), Hans Jörg Häuselmann, (unknown), Robert Theiler, (unknown), Paul Dieppe, Peter M. Villiger, Matthias Egger	116

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact